Page
%P
-
Article
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
The nuclear export receptor, Exportin 1 (XPO1), mediates transport of growth-regulatory proteins, including tumor suppressors, and is overactive in many cancers, including chronic lymphocytic leukemia (CLL), a...